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Abstract
The coordinated regulation of protein kinases is a rapid mecha-
nism that integrates diverse cues and swiftly determines appropri-
ate cellular responses. However, our understanding of cellular
decision-making has been limited by the small number of simulta-
neously monitored phospho-regulatory events. Here, we have esti-
mated changes in activity in 215 human kinases in 399 conditions
derived from a large compilation of phosphopeptide quan-
tifications. This atlas identifies commonly regulated kinases as
those that are central in the signaling network and defines the
logic relationships between kinase pairs. Co-regulation along the
conditions predicts kinase–complex and kinase–substrate associa-
tions. Additionally, the kinase regulation profile acts as a molecular
fingerprint to identify related and opposing signaling states. Using
this atlas, we identified essential mediators of stem cell differenti-
ation, modulators of Salmonella infection, and new targets of AKT1.
This provides a global view of human phosphorylation-based
signaling and the necessary context to better understand kinase-
driven decision-making.
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Introduction
Cells need to constantly adapt to internal and external conditions in
order to maintain homoeostasis. During cellular decision-making,
signal transduction networks dynamically change in response to
cues, triggering cellular state-defining responses. Multiple mecha-
nisms exist to transfer this information from sensors to the corre-
sponding molecular responses, one of the fastest being the
reversible posttranslational modification of proteins (PTMs).
Through these targeted modifications, such as phosphorylation, the
cell can quickly alter enzymatic activities, protein interactions, or
subcellular localization in order to produce a coordinated response
to a given stimulus (Pawson, 2004). Protein phospho-regulation
constitutes a highly conserved regulatory mechanism relevant for
a broad set of biological functions and diseases (Beltrao et al,
2012).
Over the past decades, our view of cellular signaling has
advanced from an idea of isolated and linear cascades to highly
complex and cooperative regulatory networks (Jordan et al, 2000;
Gibson, 2009). Different perturbations in cellular conditions often
activate different sets of interconnected kinases, ultimately trigger-
ing appropriate cellular responses. The complete understanding of
such cell fate decisions would require the systematic measurement
of changes in kinase activities under multiple perturbations, but the
small number of quantified regulatory events (i.e. tens) that were
possible to date has limited our knowledge of cellular decision-
making and its molecular consequences (Garmaroudi et al, 2010;
Bendall et al, 2011; Kim et al, 2011; Niepel et al, 2013).
Advances in mass spectrometry and enrichment methods now
allow measuring changes in thousands of phosphorylated peptides
at a very high temporal resolution (Olsen & Mann, 2013; Humphrey
et al, 2015; Kanshin et al, 2015). Recent studies on human quantita-
tive phosphorylation include responses at different cell cycle stages
(Dephoure et al, 2008; Olsen et al, 2010), after DNA damage (Beli
et al, 2012), EGF stimulation (Olsen et al, 2006; Mertins et al,
2012), prostaglandin stimulation (de Graaf et al, 2014) and different
kinase inhibitions (Hsu et al, 2011; Kettenbach et al, 2011; Weber
et al, 2012; Oppermann et al, 2013) among many others. More
recently, improvements in experimental and computational methods
have fostered the study of differential regulation of phosphosites
and kinases in different cancer types (Casado et al, 2013), the
modeling of drug resistance (Wilkes et al, 2015) and inference of
more precise pathway models (Terfve et al, 2015). We suggest that
the integrated analysis of phosphoproteomic responses after a wide
panel of heterogeneous perturbations can expedite our understand-
ing of cell decision-making processes.
In this study, we have compiled condition-dependent changes in
human protein phosphorylation derived from 2,940,379 phospho-
peptide quantifications in 435 heterogeneous perturbations. After
quality control and normalization, we infer and benchmark the
changes in 215 kinase activities in 399 conditions. We show that the
similarity of kinase regulatory profiles can be used as a fingerprint to
compare conditions in order to, for example, identify perturbations
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that modulate the kinase activity changes of a condition of interest.
The large number of conditions analyzed allowed us to identify the
kinases that are broad regulators (i.e. generalist kinases), found to
be central kinases of the signaling network. Individual kinase pro-
files across conditions were also informative to recapitulate known
kinase–kinase interactions and to identify novel co-regulated
complexes and phosphosites acting as potential effectors.
Results
Landscape of kinase activity responses under perturbation
To extensively study the heterogeneity and specificity of the human
signaling response, we compiled and standardized 41 quantitative
studies reporting the relative changes in phosphopeptide abundance
after perturbation (see Materials and Methods). From the detected
peptides, we collected identifications for 119,710 phosphosites in
12,505 proteins, 63% of which were already reported in phosphosite
databases (Fig EV1). For these sites, we normalized a total of
2,940,379 quantitative changes in phosphopeptide abundance in a
panel of 435 biological conditions covering a broad spectrum of
perturbations including targeted kinase inhibition, induced hESC
differentiation, or cell cycle progression, among many others
(Appendix Fig S1, Table EV1). Only 1% of all phosphorylated sites
were reported in more than 60% of the studies, whereas 52% of the
sites were quantified in one single study (Fig EV1). The observed
data sparsity, a common problem in shotgun proteomics, is
frequently derived from the accumulation of technical and biological
variants. To prevent the aggregation of false positives, only phos-
phosites observed in two or more independent studies were consid-
ered in downstream analysis.
In order to circumvent the problem of incomplete coverage due
to the different sets of quantified sites in each study, we avoid
analyzing individual phosphosites. Instead, we predicted the
changes in kinase activity by testing the enrichment on differentially
regulated phosphosites among the known substrates of each kinase
(Fig 1A). Using a modified version of the weighted kinase set enrich-
ment analysis (KSEA) (Subramanian et al, 2005; Casado et al,
2013), we quantified the regulation of 215 kinases in a range
between 10 and 399 perturbations (Fig 1A, Table EV2, Materials
and Methods). To verify the ability of KSEA to quantitatively
measure the changes in kinase regulation, we performed a series of
benchmark tests based on prior knowledge.
The known mechanism of action of certain biological processes
or compounds suggests different perturbations in which specific
kinase regulation is expected. For instance, the ATM (ataxia telang-
iectasia, mutated) and ATR (Ataxia Telangiectasia and Rad3-related)
kinases display direct regulation corroborated by the KSEA activities
under DNA damaging conditions (Fig 1B). Similarly, the kinases in
the MAPK/Erk pathway accurately display activation 10 min after
EGF stimulation (Fig 1B). Conversely, the KSEA estimates also
report decrease in kinase activities as in the case of the epidermal
growth factor receptor (EGFR) inhibition mediated by erlotinib and
gefitinib or mTOR inhibition by Torin1 (Fig 1B). Overall, the KSEA
activity shows predictive power to discriminate expected regulation
in 132 kinase–condition pairs (Fig 1C, Table EV3, area under the
ROC curve = 0.75).
To further validate the kinase regulation inference, we compared
the KSEA activities across conditions with the corresponding
changes in kinase regulatory phosphosites collected in the atlas. For
example, phosphorylation of the activation loop residue threonine
287 (T287), known to result in an increased catalytic activity of
AURKA, presents a significant co-regulation with the AURKA KSEA
activity (Spearman’s q = 0.6, P = 0.02). Phosphorylation of T287
and KSEA activity derived from AURKA substrates are both
decreased as AURKA inhibitor MLN8054 concentration increases
(Fig 1D). Overall, we observe a significantly higher correlation
between the KSEA activities and the changes in kinase auto-
regulatory sites (Student’s t-test, P ¼ 1:7 104) (Fig 1E). Finally,
we compared the kinase regulation with those assayed in a previous
study using phospho-specific antibodies under similar conditions
(Hill et al, 2016). As an example, the KSEA activities 10 min after
EGF stimulation significantly correlate (q = 0.53, P = 0.008) with
the antibody-based quantified phospho-regulation 15 min after EGF
stimulation (Fig 1F). Despite the differences of both assays, the pro-
file of inferred changes based on 26 phospho-dependent antibodies
and the MS-based KSEA activities for the equivalent kinases present
significantly higher correlations when cells are stimulated with simi-
lar EGFR activating conditions (Fig 1G, Student’s one-sided t-test
P ¼ 2:7 105, Appendix Fig S2).
Together, these results not only validate the activity inference for
individual kinases but strongly suggest the profile of kinase activity
changes can serve as molecular barcodes of the cellular signaling
state.
Inhibition of inferred regulatory kinases impairs state transition
during PMA-induced hESC differentiation
To further validate the inferred KSEA activities, we experimentally
measured the activity changes of 10 kinases using immunohisto-
chemistry (Table EV4) during human embryonic stem cell (hESC)
differentiation induced by Phorbol 12-myristate 13-acetate (PMA), a
perturbation compiled in the phosphoproteomic atlas (Rigbolt et al,
2011; Fig 2A and B). Immunofluorescence and KSEA substrate-
derived activities 30 and 60 min after PMA treatment agree in their
regulatory effect—activatory or inhibitory—for 14 out of the 20
quantifications (Figs 2C and EV2). Several of the concordant
changes are expected to occur during differentiation such as for PKC
(PRKCA) (Feng et al, 2012), Erk2, RSK (RPS6KA1), GSK3A, and
GSK3B (Kinehara et al, 2013). For CDK1, the predicted activities
were corroborated using an antibody targeting cyclin B1 pS126
(CycB1/CCNB1), a phosphorylation required for the activation of
the CDK1-cyclin B1 complex.
Not all regulated kinases may be functional relevant for the
process under study. To discriminate driver regulatory kinases from
secondary kinases activated as a consequence of the differentiation
process, we monitored the PMA-induced transition in the presence
of kinase inhibitors (Table EV5). Using immunofluorescence, we
quantified the cytoplasmic abundance of Oct4 and Erg1 as respec-
tive early and late markers of PMA-driven differentiation (Niwa
et al, 2000; Kinehara et al, 2014; Fig EV3, Appendix Fig S3). Inter-
estingly, Erk2 inhibition induced the strongest disruption of Erg1
expression. Inhibition of CDK1 also appears to delay the increase in
Erg1 expression and, potentially, the differentiation process. On the
other hand, the inhibition of RSK (RPS6KA1) shows the strongest
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Figure 1. Kinome-wide activity regulation derived from known substrates and 41 quantitative phosphoproteomic studies.
A Schematic of the data compilation effort and kinase activity prediction using Kinase Set Enrichment Analysis (KSEA).
B Expected kinase response after activation or inhibition. When available (n ≥ 2), error bars represent standard deviation over the mean KSEA activity.
C Receiver operating characteristic (ROC) representing the discriminative power of the KSEA activity to separate a set of 132 kinase–condition pairs expected to display
regulation. As negatives, 1,000 random sets were generated containing the same number of kinase–condition pairs from the same set of kinases and conditions.
Curve displays average ROC curve and bars standard deviation. AUC, area under the ROC curve.
D Regression analysis between Aurora kinase A (AURKA) regulatory site T287 and AURKA KSEA activity across all quantified conditions. Labeled conditions correspond to
different concentrations of the AURKA inhibitor MLN8054 under mitosis.
E Comparison between Spearman correlation coefficients obtained between KSEA-inferred kinase activities, quantifications of regulatory sites susceptible of auto-
phosphorylation (n = 56), or other regulatory sites in kinases (n = 395). The boxes represent the 1st, 2nd (median) and 3rd quartiles and the whiskers indicate 1.5 times
the interquartile range (IQR). Two-sided Student’s t-test *P = 1.7 × 104.
F Linear regression between KSEA activities 10 min after EGF stimulation and activities measured with RPPA targeting regulatory phosphorylations 15 min after
adding EGF.
G Spearman correlation coefficients between the profile of 24 kinase activities estimated with KSEA 10 min after EGF stimulation (n = 40) and the activities of the
same kinases measured with RPPA after stimulating the cell with different ligands. EGFR ligands, EGF or NRG1; other growth factors (GF), HGF, IGF, insulin, or FGF
(n = 70); or control conditions, serum or PBS (n = 40). The boxes represent the 1st, 2nd (median) and 3rd quartiles and the whiskers indicate 1.5 times the IQR. Two-
sided Student’s t-test **P = 0.005. ***P = 0.004.
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induction of Erg1 expression after treatment, suggesting a possible
role of its activity in the maintenance of the pluripotent state. The
inhibition of GSK and S6 (RPS6KB1) kinases results in a small
increase in PMA-induced Erg1 expression only during the early time
points. Overall, these results show how the KSEA-based inference
can predict regulated kinases and therefore predict those that are
more likely to be functionally relevant in specific conditions. This
illustrates how the kinase atlas can serve as a useful cell signaling
resource.
Kinase regulation profiles as molecular fingerprints of cellular
signaling states
The diversity of the compiled perturbations as well as the extent of
the kinases for which regulation is inferred constitutes a resource to
study fundamental aspects of cell signaling. To demonstrate that the
biological variation dominates over the technical variation, we
tested whether related kinases display co-regulation across condi-
tions and, similarly, related conditions show similar patterns of
kinase regulation. We observed that significant correlations between
the KSEA activities were more frequent between kinases one or two
steps away in the pathway than between those farther away (Fig
EV4A). This observation remains true when excluding kinase pairs
sharing substrate sites (Fig EV4B). Similarly, we confirmed that
pairs of related conditions measured in different studies tend to
have similar profiles of KSEA activities (Fig EV4C). Furthermore,
the correlation of kinase regulatory profiles is a very strong predic-
tor of related conditions assayed in different studies (Fig EV4D,
AUC = 0.93), but not of pairs of conditions from studies conducted
in the same laboratory (AUC = 0.499), with the same cell line
(AUC = 0.546) or with the same labeling method (AUC = 0.475).
These results strongly suggest that the variation in kinase activities
across conditions is primarily driven by biological effects rather than
technical variation.
In order to explore the space of different signaling responses, we
performed a principal component analysis (PCA) using the kinase
regulation profiles derived from 58 well-characterized kinases
(Fig 3A, Materials and Methods, Appendix Fig S4). The first two
components separate related EGF conditions based on their
expected signaling similarities and opposite to the EGFR pathway
inhibitors (Fig 3A, symbols). The separation of perturbations in the
reduced space is again independent of the publication of origin,
reflecting instead the similarities in the signaling response. The
systematic exploration of conditions in the reduced space also
allows us to investigate commonalities in the decision-making
process. Kinase loadings driving the sample separation in the PCA
space reflect systematic differences on the regulation of different
kinases (Appendix Fig S4C). In this way, we can identify different
types of kinase logic relationships that apply to nearly all conditions
(Fig 3B). Some kinase pairs are co-regulated—such as BRAF and
A C
B
Figure 2. Inhibition of inferred regulatory kinases impairs PMA-induced differentiation of hESC.
A Representative images of differentiation marker MAPK (pT202/Y204) expression in hESCs stimulated with PMA. Scale bars: 30 lm.
B Time course quantification of MAPK activation levels after PMA stimulation in the presence or absence of MAPK inhibitor (PD184352). Bars represent mean  SD
(n > 1,000).
C Relative changes in kinase activities using Kinase Set Enrichment Analysis (KSEA) benchmarked against antibody-measured reporter phosphosites in the intervals
0–30 and 0–60 min.
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PRKG1 (Fig 3B, AND)—or anti-correlated—such as CDK2 and CHEK
(Fig 3B, OR). Alternatively, we also identify pairs of kinases that
display exclusive regulation, whereby one is never regulated at the
same time as the other. For example, AKT1 is regulated when CDK1
is not and vice versa (Fig 3B, NOT).
The results above show how extreme similarities or dissimilari-
ties between profiles of activity changes facilitate the interpretation
and generate hypothesis about the signaling in specific conditions.
For example, perturbations under DNA damaging conditions display
similar KSEA activity profiles that can be summarized as a signature
of marker kinases (Fig EV5). Among the most similar conditions to
two DNA damage conditions (ionizing radiation and etoposide) are
compounds that are known to cause DNA damage and a sample
under G1-S transition obtained using a thymidine block that likely
resulted in DNA damage. Conversely, cells treated with the inhibitor
VE-821 targeting the DNA damage response kinase ATR show
changes in activities anti-correlated with DNA damaging conditions
(Fig EV5C). Therefore, kinase regulatory profiles can be used to
identify perturbations that may mimic or modulate the kinase regu-
lation occurring in a condition of interest. We further explored this
notion in the study of two related Shigella and Salmonella infection
states (Fig 3E). Among the anti-correlated conditions are 4
compounds that could potentially interfere with the infection
process or the host response: SB202190 (p38 MAP kinase inhibitor),
mesalazine (anti-inflammatory), trichostatin A (HDAC inhibitor),
and verapamil (an efflux pump inhibitor). To validate the effect of
A B
C D E
Figure 3. Kinase activity profiles as fingerprints of the cell signaling state.
A Perturbation scores on the first two PCA components based on KSEA activity profiles of 52 well-characterized kinases. Symbols represent EGF-related perturbations
in different studies.
B Boolean logic relationships between kinase responses. Samples in two first components are colored by different KSEA activities. Vectors display kinase loadings.
C Network displays significantly correlated or anti-correlated conditions in the context of early responses after bacterial infection. The strength of the correlations
(blue) and anti-correlations (red) is displayed as the edge width.
D, E Infection rate at 0 h (D) and bacterial proliferation after 20 h (E) when adding different concentrations of compounds displaying anti-correlated KSEA activity
profiles with early responses after bacterial infection (4 biological replicates). Displayed significant ANOVA P-values evaluate differences between three drug
concentrations and the DMSO control. The horizontal lines represent the median baseline value for the Infection + DMSO control.
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these compounds, we have measured their impact on the invasion
and proliferation of Salmonella enterica serotype Typhimurium
(STm) in human cells (Fig 3D, Materials and Methods). Mesalazine
showed no effect on either invasion or proliferation (data not
shown). Trichostatin A and higher doses of SB202190 tend to
promote invasion. SB202190 showed a consistent decrease in long-
term STm proliferation while trichostatin A showed a trend for
increase in STm proliferation that was clearer for lower doses of the
drug. Verapamil had a significant effect on proliferation that was
not consistent across different concentrations. These results show
how modulators of signaling states of interest can be identified by
comparing kinase regulatory profiles found in the atlas.
Activity signatures reveal generalist and specialist kinases
The large panel of estimated changes in kinase activity across condi-
tions allows us to classify kinases according to their degree of speci-
ficity. Some kinases, such as AKT or CDK1, are very often regulated
across all conditions and can be defined as generalist kinases. Other
kinases such as ATM and ATR are more narrowly regulated and can
be considered specialist kinases. To study these two classes of
kinases, we correlated the number of conditions in which kinases
show changes in activity with the functional importance of the
kinases measured in genetic experiments. Functional importance
was scored as either the degree of essentiality from a CRISPR screen
(Wang et al, 2015) or by the number of phenotypes from a compila-
tion of RNAi screens (from www.genomernai.org) (Fig 4A and B).
Kinases that have changes in activity in many conditions (e.g.
generalist kinases) are not more likely to be functionally important
than specialist kinases. For example, ATR or PLK1 are regulated in
few conditions but tend to be essential. We observed however that
generalist kinases, such as AKT and CDK1, are more central in the
kinase signaling network as measured by the number of shortest
paths that traverse them in the directed kinase–kinase network (Fig
4C, q = 0.506, P ¼ 9:8 103, excluding kinases with 0 between-
ness). Kinases that are often regulated tend to occupy positions in
the network where signaling is very likely to flow through based on
the wiring of the network. Understanding the properties of general-
ist and specialist kinases may allow us to better understand the
specificity of the signaling response, as well as to propose novel
therapeutic targets and inform on the potential consequences of
kinase inhibition.
Kinase co-regulation identifies novel molecular effectors
The conditional depth of the kinase regulation atlas facilitates the
search for co-regulated kinases and potential molecular effectors.
Protein complexes are common signaling effectors that often display
coordinated phospho-regulation with regulatory kinases. To search
for kinase–complex co-regulation, we quantified the enrichment of
regulated phosphosites within stable human complexes. We then
correlate this enrichment with the KSEA activities across the panel
of biological perturbations (Materials and Methods). Kinase–
complex associations were validated if at least one subunit in the
complex was a known substrate of the kinase. Overall, we found a
very strong enrichment for known kinase targets among the kinase–
complex associations predicted from co-regulation (Fig 5A,
Table EV6). Using CDK1 as an example, we found a significant
number of co-regulated complexes validated as direct substrates of
CDK1 based on previous evidence, even though the actual substrate
sites in the complex were not used to predict their association (Fig
5B). We have also identified examples of complex subunits func-
tionally related to CDK1, but with no evidence yet of direct regula-
tion. The chromatin assembly complex (CAF-1 complex), for
instance, delivers newly synthesized H3/H4 dimers to the replica-
tion fork during the DNA synthesis (S) phase, shifting to secondary
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Figure 4. Relevance of generalist or specialist kinases.
A Genetic relevance of generalist and specialist kinases. Number of conditions where the kinase is regulated (absolute estimated kinase activity > 1.75) for each kinase
with more than 10 known substrates against the depletion score from CRISPR essentiality screen (Wang et al, 2015). A lower depletion score is indicative of kinases
that cause severe fitness defects when knocked-out.
B Same number of conditions in which a kinase is regulated against the number of phenotypes shown by the knocked-down kinase (from a compilation of RNAi
screens www.genomernai.org).
C Same number of conditions in which a kinase is regulated against kinase centrality (betweenness) in signaling network. In the inner panel, a diagram illustrates the
relationship between betweenness and the signaling network connectivity. Generalist kinases with more than 10 known substrates tend to have also high
betweenness scores (Spearman’s q = 0.506, P = 9.8 × 103). Kinases without shortest paths going through them were excluded.
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functions during other stages of the cell cycle (Volk & Crispino,
2015). Although no specific site in the complex has been validated
as CDK1 substrate, the observed co-regulation of CAF-1 and CDK1
(r = 0.27, FDR ¼ 5 104) was partially validated in vitro as CDK
inhibition prevents the replication-dependent nucleosome assembly
in human cell extracts (Keller & Krude, 2000).
As an additional application of this approach, we tested whether
co-regulation can also be predictive of novel AKT1 kinase target
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Figure 5. Kinase co-regulation reveals candidate molecular effectors.
A Systematic evaluation of the kinase–complex associations based on the known direct interactions between kinases and complexes. The positive predictive value (PPV)
is displayed against the false discovery rate (FDR). The baseline random expectation (in gray) represents the PPV of a random predictor trying to estimate associations
between kinases and complexes.
B Protein complexes showing correlated phospho-regulation with the activity of CDK1. The complexes marked in green contain at least one substrate of CDK1. Only the
top correlated complexes are shown for the sake of clarity. Missing activities are displayed in white.
C Experimental workflow to study phosphoproteome dynamics under AKT (AKT1) inhibition in insulin-stimulated HeLa cells.
D Quantification of known kinase substrates after AKT inhibition of insulin-stimulated cells for all kinases with at least 14 known sites (top left) and their respective
KSEA enrichment after 10,000 permutations (bottom left). Regulation under AKT inhibition of the top 24 unknown sites (number of quantified AKT known substrates)
ranked based on their motif similarity, co-regulation with the known substrates or the combination of both (top right) and their corresponding enrichment on
regulated sites after inhibition (bottom right).
E List of high-confidence AKT substrates fulfilling the following criteria: down-regulation on AKT inhibition log2 L/H < 0.9, positive co-regulation P < 0.01, motif
similarity log-weights > 0.8, mss > 0.6, and all sites reported as in vitro substrates of AKT (Imamura et al, 2014).
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sites. In order to validate these predictions, we measured the phos-
phorylation changes of 15,255 phosphosites in insulin-stimulated
HeLa cells in the presence or absence of the AKT inhibitor VIII (Fig
5C, Table EV7). As expected, previously known AKT targets are, on
average, down-regulated in the presence of the inhibitor (Fig 5D).
Additionally, the substrates of downstream related kinases, such as
mTOR or GSK, are also regulated. When predicting the same
number of AKT targets as either sites strongly matching the AKT
sequence preference or sites showing the most significant co-
regulation with AKT across conditions, the latter showed much
stronger down-regulation after AKT inhibition (Fig 5D).
In order to propose a list of new bona fide AKT targets, we short-
listed those that are strongly co-regulated with the AKT activity
(P < 0.01), match the AKT sequence preference, are down-regulated
after AKT inhibition (log2L/H <0.9), and were also reported as
in vitro AKT substrate sites (Imamura et al, 2014). We identified 12
AKT target phosphosites matching these stringent criteria (Fig 5E,
Table EV8). S588 of TBC1D4 was previously described to be a
potential AKT target sites, despite it not being present in our training
set (Berwick et al, 2002; Kane et al, 2002). The tumor suppressor
PDCD4 has also been shown to be regulated by AKT but at position
S67 controlling its localization (Palamarchuk et al, 2005). We identi-
fied S76 as an AKT target, a residue important for PDCD4 degrada-
tion (Galan et al, 2014; Matsuhashi et al, 2014) that is
phosphorylated under EGF stimulation (Matsuhashi et al, 2014).
This suggests that AKT activity may directly control the protein
levels of PDCD4. Another interesting target site is S801 of the
kinesin KIF4A, a motor protein involved in the control of micro-
tubule stability. The nearby position T799 is a target of Aurora B
and the double alanine mutant T799A/S801A has impaired function
(Nunes et al, 2013). In addition, both AKT and KIF4A regulate
microtubule stability during cell migration (Onishi et al, 2007;
Morris et al, 2014). Taken together, these results suggest that AKT
directly targets KIF4A S801 and that this interaction plays a role in
microtubule stabilization during migration.
Discussion
Changes in internal or external conditions are sensed by cells which
rapidly make decisions on how to mount an appropriate response.
Difficulties in measuring activities and downstream consequences
for a large number of kinases have limited the comprehensive
understanding of the decision-making process. Here, we have
compiled the changes in the human phosphoproteome across 399
perturbations, in order to create an atlas of regulation for 215
kinases, as well as the phospho-regulatory status of hundreds of
effector protein complexes.
One of the main limitations preventing the integration of MS
quantitative data has been the stochasticity of the peptide discovery.
In this study, we have demonstrated how the analysis of sets of
phosphosites (e.g. all kinase substrates) can help overcome the lack
of coverage on phosphosite quantifications. The enrichment on
biologically meaningful sets of sites also increases the robustness
against technical variability, mostly due to differences in experimen-
tal protocols and analysis pipelines. Several results suggest the vari-
ation in kinase activities along conditions in our compendium is
driven by biological factors: Related conditions have similar profiles
of kinase regulation (Fig EV4C and D); pairs of related kinases
are co-regulated across the conditions (Fig EV4A and B); and co-
regulation between kinase activity and effectors is predictive of
kinase–target interactions (Fig 5). These results strongly indicate
that this compendium constitutes a resource to identify novel
biological associations. The measured changes in phosphorylation
were not normalized for the changes in total protein abundance for
the conditions compiled for this study. In particular, for longer time-
scales this could be a confounding effect that should also be miti-
gated by the analysis of sets of sites. The described analysis can be
periodically updated as new kinase targets are characterized and
new human perturbation experiments refine the map of signaling
responses. As such, we will maintain a growing online application
(http://phosfate.com), where the community can explore the signal-
ing regulation of all conditions in the atlas and analyze and compare
their own phosphoproteomic datasets.
The larger number of perturbations identifies the possible
roles of kinases and how they relate to each other. We have
shown that generalist kinases do not tend to be more essential
than specialist kinases but, instead, tend to be more central in the
signaling network. One interpretation would be that generalist
kinases are often regulated simply because they are located in the
network where signals flow through more often. Recent phospho-
proteomic studies of high temporal resolution have indicated that
changes in phosphorylation occur in a timescale of seconds
(Humphrey et al, 2015; Kanshin et al, 2015). Some fraction of the
later changes in phosphorylation may be non-functional and poten-
tially be consequence of the signaling propagating through the
kinase signaling network (Kanshin et al, 2015). An alternative
hypothesis could be that generalist kinases, central to the signaling
network, can be robust to perturbation and the signal modulated
by other kinases.
By comparing kinase and complex regulation in different signal-
ing contexts, we have shown tight co-regulation between regulators
and effectors that served to prioritize candidate interactions.
However, regulation of substrate phosphosites or protein complexes
is just one of the several potential consequences of a signaling
response. Given the ease in collecting cellular phenotypes or large-
scale biological measurements such as gene expression and metabo-
lites, we propose this approach can be generalized to globally study
the diversity of cellular molecular states. Additionally, as data from
specific genetic backgrounds (e.g. cancer cell lines or primary
tumors) become available, this research could help to interpret the
actionable signaling consequences derived from specific sets of
mutations, drawing a much more complete diagnostic of the cellular
state.
Materials and Methods
Compilation of human quantitative phosphoproteomic data
The atlas integrates a compilation of 41 selected publications report-
ing human MS-derived changes in phosphopeptide abundance
under 435 perturbations. In order to consider a dataset for the atlas,
we required peptide sequences, phosphorylation identifications, and
detailed description of the biological perturbation and control for a
minimum of 1,000 phosphopeptides (Table EV1). From the 41
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studies included, only the raw spectra derived from 16 studies were
made available in public repositories. Three additional studies were
deposited in the no longer available Tranche. The different labeling
methodologies make difficult the processing of the public spectra
with a common pipeline. Additionally, due to the poor metadata
annotation of some of the conditions, reprocessing the spectra
would not be possible for some of the datasets. For these reasons,
we relied on the original MS identifications performed by the experi-
mental groups. We collected all quantifications from the supplemen-
tary data available in each of the 41 studies, including both
significant and not significant changes. To standardize the peptide
sequences and site positions across studies, we mapped all peptides
to the same reference proteome using Ensembl v73 (Cunningham
et al, 2015). For data storage purposes, we mapped the peptide
quantifications to all matching protein isoforms and transformed all
quantifications into log2 ratios. Finally, the remapped 2,940,379
phosphopeptide quantifications and all their metadata were stored
in a MySQL database that is publicly available in the Downloads
section of http://phosfate.com.
Data preprocessing and normalization
To standardize and further compare the datasets, we applied a
series of quality control criteria. (i) We restricted the analysis to
peptides mapped in the Ensembl canonical transcripts, resulting in
12,427 canonical phospho-modified proteins. According to Ensembl,
the canonical transcripts correspond to the longest Consensus CDS
(CCDS) model in each gene (Pruitt et al, 2009). (ii) The quantified
changes of peptides with the same set of modifications but different
sequences were merged into one single entry, therefore increasing
the conditional coverage. On those cases where more than one
quantified peptide contains the same set of modifications for the
same condition, their ratios were averaged. (iii) The conditional
ratios between technical replicates were averaged, while remaining
separated for biological replicates. (iv) Only monophosphorylated
peptides were considered for all subsequent analysis requiring
quantifications at single positions. (v) To prevent the accumulation
of false-positive sites, modified positions identified only in one
single study were excluded. (vi) We quantile-normalized the quan-
tifications across conditions and excluded all conditions with
< 1,000 peptide quantifications. After applying all these quality
control criteria, the size of the final set of conditions was reduced
from 435 to 399 perturbations (Appendix Fig S1). On this reduced
set of conditions, we considered for further analysis a total of
1,238,987 quantifications for 43,028 more reliable monophosphory-
lated peptides.
Kinase set enrichment analysis
To estimate the kinase regulation from the differential regulation of
their known substrates, we modified the original kinase set enrich-
ment analysis to incorporate the principles of the weighted Gene Set
Enrichment Analysis (Subramanian et al, 2005; Casado et al, 2013).
This modified KSEA uses the Kolmogorov–Smirnov statistical test to
assess whether a predefined set of kinase substrates is statistically
enriched in phosphosites that are at the two of extremes of a ranked
list defined by their differential regulation. This algorithm is particu-
larly helpful to detect changes on phosphosite regulation in the
context of all site quantifications, even though the changes in site
quantifications could be small. Moreover, the algorithm do not
require any arbitrary threshold to define which phosphosites are
significantly regulated or not. As in the GSEA algorithm, all site
quantifications are considered in order to search for enrichments
within the extreme fold changes. The KSEA algorithm proceeds as
follows: (i) The Enrichment Score (ES) is calculated by walking
down the ranked site quantifications and rescoring a running-sum
statistic. The statistic is increased by the site quantification when it
encounters a substrate of the kinase and decreases when the site is
not a substrate. Both increases and decreases are normalized by the
total number of known and not known substrates and proportional
to the observed fold change. Finally, the ES corresponds to the
maximum deviation from zero—either positive or negative—
encountered in the walking down. The metric is equivalent to a
weighted Kolmogorov–Smirnov-like statistic. (ii) The null distribu-
tion of ES is calculated by randomizing the sites but preserving the
same distribution of site quantifications. (iii) The statistical signifi-
cance of the observed ES is calculated using the empirical P-values
calculated from the ES null distribution based on the same number
of known substrates and the same distribution of quantifications.
An R package implementing the novel KSEA described above is
provided at https://github.com/evocellnet/ksea.
Predicting kinase activities using KSEA
In order to collect a comprehensive list of regulatory relationships,
we merged all the interactions reported in PhosphoSitePlus
(Hornbeck et al, 2015), HPRD (Keshava et al, 2009) and Phos-
pho.ELM (Dinkel et al, 2011) in June 2014. After excluding kinase
auto-phosphorylations, we compiled a total of 7,815 interactions
between 306 kinases and 5,617 individual sites. Using the above
described regulatory information and the collected quantitative
phosphoproteomic data, we applied the KSEA algorithm with a null
distribution of 1,000 permutations per kinase and condition. In
order to use the enrichment significance as a proxy of kinase
activity, the resulting P-values were log10-transformed and signed
based on the average sign of all substrates. If the predominant
change of all substrates is an increase in phosphorylation, the
kinase is predicted as activated. If the majority of the substrates
present reduced phosphorylation, the kinase is predicted as
inactivated.
Kinase activity validation using kinase regulatory sites
To corroborate the kinase activity inference, KSEA activities were
compared with the phosphorylation changes observed in kinase
regulatory sites across conditions. From the total list of 941 human
regulatory sites reported in PhosphoSitePlus, 150 were quantified in
at least 10 perturbations. To evaluate the concordance between the
KSEA activities and the quantitative changes in the regulatory phos-
phorylations, we performed a linear regression analysis across all
available perturbations. Additionally, the results with those derived
from the Spearman correlations between the kinase activities
and the regulatory sites susceptible of auto-phosphorylation and
other sites not reported to regulate the enzymatic activity. We
discarded all kinase activity profiles under no regulation (absolute
log P-value > 1 in at least 1 condition).
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Kinase activity validation using RPPA data
We compared the predictions based on the collected quantitative
phosphoproteomic data with the antibody-based kinase activities
from a previous study (Hill et al, 2016). We used the BT20 cell line
as reference, showing the most responsive quantitative profiles after
EGF receptor stimulation. We scaled the antibody-based measure-
ments to make them comparable across conditions and antibodies.
We quantile-normalized per antibody to assure equal final distribu-
tions. Next, we standardized each individual combination of cell
line, inhibitor, stimulus, and time point by calculating the z-score of
each of the measurements based on the mean and standard deviation
of the unstimulated conditions. Replicates were averaged. The final
dataset contains 26 quantifications reporting changes in regulatory
phosphosites in kinases. In order to use only the most reliable activ-
ity predictions, kinases with a number of known substrates smaller
than 5 were excluded. To circumvent the effect of protein abun-
dances, we restricted the analysis to the first hour after EGF stimula-
tion. The normalized quantifications clustered together based on the
sample similarities, with no apparent batch effects (Appendix Fig
S1). The DREAM conditions were classified depending if they acti-
vate EGFR—EGF and NRG1—other growth factors that eventually
could have a similar downstream effects—HGF, IGF1, FGF1, and
insulin—or non-stimulating conditions—serum and PBS.
Maintenance and treatment of human embryonic stem
cells (hESCs)
Human embryonic cells, H1 and H9 (WA01, WA09 from WiCell),
were maintained on Matrigel (BD Biosciences)-coated dishes in
mTeSRTM1 medium (StemCell Technologies). Differentiation of
hESCs was induced by supplementing mTeSRTM1 with PMA 50 nM.
Differentiation time course experiments were typically 0, 30 min, 1,
6 and 24 h. Kinase inhibition experiments were performed by
supplementing mTeSR1 medium with pharmacological inhibitors
1 h before PMA treatments (Table EV8). In order to avoid inhibitor’s
degradation during 24-h experiment, fresh mTeSR1 medium with a
50 nM of PMA was changed after 10 h.
hESC immunofluorescence and image analysis
For each time course experiment, hESCs were fixed for 10 min with
a 4% paraformaldehyde, permeabilized for 5 min with 0.3% Triton
X-100, and incubated with a blocking solution (10% fetal bovine
serum (FBS) and 3% bovine serum albumin (BSA) in PBS) for 1 h.
Primary antibodies (Table EV7) were incubated overnight at 4C in
antibody dilution buffer (1% bovine serum albumin (BSA), 0.1%
Triton X-100 in PBS) at the indicated concentrations. Primary anti-
bodies were visualized by using a secondary antibody conjugated to
Alexa 488. Samples were counterstained with DAPI to facilitate
analysis. Images were acquired using a high-content, widefield
inverted microscope, Olympus ScanR System equipped with a
sCMOS Flash 4.0 camera (Hamamatsu), universal plan semi-
apochromat 20× objective (NA 0.7), and a SpectraX LED light
source. Image analysis was performed using MATLAB or CellPro-
filer (Carpenter et al, 2006). Briefly, a low-pass Gaussian filter was
first applied to each image. The local background value of each
pixel was then determined by searching for a surrounding ring area,
with the outer and inner radii of the ring being 10 and 5 times the
approximate nuclear radius, respectively. The lowest 5th percentile
value of the ring area was used as the background intensity of the
center pixel. Cell nuclei were identified using fluorescent DAPI
images as masks. When needed, cytoplasmic mask consisted of a
ring around the nucleus. The MATLAB function regionprops was
then used to label each nucleus and to retrieve the xy coordinates of
all pixels in specific nuclei. The level of immunofluorescence stain-
ing in each cell was calculated as the average value of the intensities
from each pixel of the specific nucleus. At least 2,000 cells were
used for analysis per each indicated condition.
PCA based on kinase activity profiles
To restrict the analysis to consistently estimated kinases, only
those inferred in at least 75% of the perturbations were consid-
ered. Conditions displaying extreme redundancies were also
excluded, reducing the matrix of kinase activities to 58 kinases and
387 conditions. For the 7.43% of the matrix containing missing
values, the data were imputed using the regularized iterative PCA
algorithm implemented in the imputePCA function contained in the
R package missMDA. Using the resulting complete matrix, principal
components analysis (PCA) was performed using the rda function
in the R package vegan without any additional scaling. The
expected (baseline) percent variance in each PC stemming from
noise in data was estimated using the stringent “broken stick"
method and the relaxed average eigenvalue (Kaiser–Guttman crite-
rion) (Jackson, 1993).
Salmonella strains used for infection
Salmonella enterica serovar Typhimurium 14028s (STm) trans-
formed with the constitutive GPF expressing plasmid pDiGc
(Helaine et al, 2010) were cultivated in LB broth (Miller) containing
100 lg/ml ampicillin by incubating on a rotating wheel at 37C.
HeLa cells (ATCC) were cultivated in DMEM 4.5 g/l glucose (Gibco
cat. 41965-039), pyruvate (100 mM, Gibco), 10% FBS at 5% CO2 in
a 37C incubator. Stock drug solutions were dissolved in DMSO:
trichostatin A (Sigma cat. T8552) and SB202190 (Sigma cat. S7067),
or methanol: ()-verapamil hydrochloride (Sigma cat. V4629). Final
drug concentrations used trichostatin A: 1.5, 1.0, and 0.5 lM;
SB202190: 15, 10, and 5 lM; ()-verapamil hydrochloride: 15, 10,
and 5 lM. 100 mg/ml stock solution of gentamicin was dissolved in
water (Sigma cat. G1914). Bacteria were prepared for HeLa cell
invasion as previously described (Helaine et al, 2010) with the
following modifications: Overnight cultures of GFP expressing STm
were diluted 1:33 into fresh LB broth and cultured for 3.5 h at 37C
prior to infection.
HeLa cell preparation and infection
At 80% confluency, 3,000 HeLa cells per well were seeded into a
384-well clear-bottom plate (Greiner cat. 781090) using a cell
seeder (Thermo, Multidrop Combi) followed by an 18-h incubation
overnight to allow cell attachment. Cells were then exposed to
indicated drug concentrations in the presence of DMEM 1 g/l
glucose + 10% FBS for 6 h. Prior to infection, cells were then
washed two times with DMEM or PBS, followed by media
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replacement with fresh DMEM 1 g/l glucose + 10% FBS. Infection
was carried out as previously described [16] using a liquid handler
(Biomek FXP). STm was added directly to HeLa cells at an MOI of
100 in PBS. STm was then allowed to invade HeLa cells by incu-
bating for 30 min at 5% CO2 in a 37
C incubator. Extracellular
STm were then removed by washing three times with warm PBS,
followed by treatment with 100 lg/ml gentamicin in DMEM 1 g/l
glucose + 10% FBS for 1 h. Media were then replaced with
10 lg/ml gentamicin in DMEM 1 g/l glucose + 10% FBS for the
remainder of the experiment n.b. This step was considered t = 0.
At the indicated time points, cells were then washed with
prewarmed PBS prior to fixation and permeabilization in 5%
formaldehyde/0.2% Triton X-100 in PBS for 45 min. Fixing solu-
tion was then removed by washing with PBS and cells were
stained using 2.5 lg/ml Hoechst33342 (Molecular Probes cat.
H3570) and 80 ng/ml Phalloidin-Atto700 (Sigma cat. 79286) over-
night at 4C. Prior to imaging, cells were washed three times in PBS.
Salmonella microscopy and image analysis
384-well plates were imaged using a Molecular Devices, IXM XL
microscope where six sites per well were imaged at 20× magnifi-
cation. CellProfiler was used to analyze the images. Nuclear regions
were determined by setting a manual intensity threshold for the
DAPI channel. Nuclei were expanded using the actin staining to
determine the cellular regions. Salmonella colonies were determined
by manual thresholding. Segmented cells were classified as infected
or non-infected depending on the presence or the absence of a
Salmonella colony in a cell region. For every site imaged, the
number of infected and non-infected cells was determined, along
with the integrated Salmonella fluorescence intensity inside infected
cells. To determine the percentage of infected cells per well, the
number of infected and non-infected cells from the six sites of every
well was summed up and the ratio of infection was calculated. In
addition, the mean integrated intensity of Salmonella in infected
cells was determined for every site, and the average value for the
six sites in a well was calculated to obtain the mean integrated
intensity of Salmonella in infected cells per well as a measure of
Salmonella intracellular proliferation.
Co-regulation between driver kinases and effector complexes
We first quantified the phospho-regulation of stable human
complexes [from the CORUM database (Ruepp et al, 2010)] in each
condition. We limited the complex redundancy by subsetting the
interactions in which only one copy of the homologous protein
complexes is included. For each of the 1,331 complexes and for each
condition, we compared the distribution of absolute changes in
phosphosite abundance in the complex against all phosphosites
using the Kolmogorov–Smirnov (KS) test. The resulting P-values
were log-transformed and signed based on the average fold change
of all sites in the complex. We then fitted a linear regression to esti-
mate those responses in protein complex phosphorylation that
correlate with changes in kinase activity across conditions. For vali-
dation purposes and in order to avoid potential biases, the kinase
substrates used to predict the kinase activities were excluded from
the complex regulation estimates. The Pearson correlation P-values
were corrected for multiple testing.
SILAC labeling, protein extraction, and digestion
HeLa cells were passaged in DMEM (-Arg, -Lys) with penicillin–
streptomycin, 10% dialyzed FBS at 37C, 5% CO2, supplemented
with either normal L-lysine and L-arginine (light K0, R0) or
13C6-
15N2 lysine and
13C6-
15N4 arginine (heavy K8, R10). Both popu-
lations of cells were deprived of serum overnight. “Light" labeled
cells were treated with 1 lM Akt inhibitor VIII for 30 min prior to
stimulation with 100 nM insulin for an additional 30 min. “Heavy”
labeled cells were stimulated with 100 nM insulin for 30 min. At the
time of harvest, cells were washed three times with ice-cold PBS
and flash frozen over liquid nitrogen. Cells were scraped into ice-
cold urea buffer (8 M urea, 75 mM NaCl, 50 mM Tris–HCl pH 8.2,
complete protease inhibitor cocktail (Roche), 50 mM sodium fluo-
ride, 50 mM beta-glycerophosphate, 1 mM sodium orthovanadate,
10 mM sodium pyrophosphate). Protein concentration was assayed
using the BCA method and lysates from “light" and “heavy"
cultures were mixed in a 1:1 ratio. Protein lysates were reduced with
5 mM DTT for 30 min at 55C, alkylated with 10 mM iodoac-
etamide for 15 min at room temperature, and quenched with
10 mM DTT. Proteins were diluted twofold with 50 mM Tris pH 8.8
and digested with Lys-C (Wako) overnight at room temperature.
The resulting peptides were desalted over a tC18 Sep-Pak cartridge
(Waters) and dried by lyophilization.
Strong cation exchange (SCX)/Immobilized metal affinity
chromatography (IMAC)
Approximately 3 mg of peptides was resuspended in 50 mM Tris pH
8.2 and further digested with trypsin (Promega) overnight at 37C.
The resulting tryptic peptides were desalted over a C18 Sep-Pak
cartridge (Waters) and dried by vacuum centrifugation. They were
separated by strong cation exchange into 12 fractions using a vola-
tile binary solvent system (A: 10 mM NH4HCO2 + 25% MeCN +
0.05% FA, B: 500 mM NH4HCO2 + 25% MeCN + 0.05% FA). Frac-
tions were dried and desalted by vacuum centrifugation. Fractions
were resuspended in 100 ll IMAC loading solution (80%
MeCN + 0.1% TFA). To prepare IMAC slurry, Ni-NTA magnetic
agarose (Qiagen) was stripped with 40 mM EDTA for 30 min,
reloaded with 10 mM FeCl3 for 30 min, washed three times, and
resuspended in IMAC loading solution. To enrich phosphopeptides,
50 ll of 5% bead slurry was added to each fraction and incubated
with rotation for 30 min at room temperature, washed three times
with 150 ll 80% MeCN, 0.1% TFA, and eluted with 60 ll 1:1
MeCN:1% NH4OH. The eluates were acidified with 10% FA and
dried by vacuum centrifugation for LC-MS/MS.
LC-MS/MS
Phosphopeptide-enriched samples were resuspended in 4% formic
acid and 3% MeCN and subjected to liquid chromatography on an
EASY-nLC II system equipped with a 100-lm inner diameter ×
40 cm column packed in-house with Reprosil C18 1.9 lm particles
(Dr. Maisch GmbH) and column oven set to 50C. Separations were
performed using gradients of 9–32% MeCN in 0.125% formic acid
ranging in length from 55 to 105 min and were coupled directly with
a LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher) config-
ured to conduct a full MS scan (60k resolution, 3e6 AGC target,
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500 ms maximum injection time, 300–1,500 m/z) followed by up to
20 data-dependent MS/MS acquisitions on the top 20 most intense
precursor ions (3e3 AGC target, 100 ms maximum injection time,
35% normalized collision energy, 40-s dynamic exclusion).
LC-MS/MS data processing
Raw data files were converted to mzXML and searched using Comet
version 2015.01 against the human SwissProt database including
reviewed isoforms (April 2015; 42,121 entries) allowing for binary
(all or none) labeling of lysine (+8.0142) and arginine (+10.0083),
and variable oxidation of methionine, protein N-terminal acetyla-
tion, and phosphorylation of serine, threonine, and tyrosine resi-
dues. Carbamidomethylation of cysteines was set as a fixed
modification. Trypsin (KR|P) fully digested was selected allowing
for up to two missed cleavages. Precursor mass tolerance was set to
50 ppm and fragment ion tolerance to 1.0005 Daltons. Search results
were filtered using Percolator to reach a 1% false discovery rate at
the PSM level. Peak area heavy/light ratios were calculated using an
in-house quantification algorithm. Phosphosite assignment was
performed using an in-house implementation of Ascore, and sites
with Ascore ≥ 13 were considered localized (P = 0.05). Phospho-
peptides in the database with multiple non-localized instances span-
ning the same sequence were only considered to correspond to the
minimum number of phosphosites that explain the data. Finally, the
dataset was additionally filtered to reach a site-adjusted false discov-
ery rate of 1%.
Co-regulation between AKT and potential new substrates
For all human phosphorylated residues compiled in the atlas, a
series of evidences were generated in order to weight their potential
role as substrates of AKT. Firstly, all sites in the atlas were matched
against the position weight matrixes (PWM) generated from all the
known substrates of AKT. To weight the motif—PWM similarity,
two algorithms were compared with similar results: the sum of the
log weights of the matched residues and the MSS score provided by
MATCH, which incorporates the information content of the PWM
(Kel et al, 2003; Wasserman & Sandelin, 2004). Secondly, the afore-
mentioned inference of kinase activities based on the known kinase
substrates was used to find sites co-regulated with the known
substrates of AKT. The response of all sites in the atlas across the
panel of conditions was correlated with the estimated activity of
AKT in the same conditions. We also included as an additional vali-
dation the set of 1,778 AKT in vitro substrates described by
Imamura et al (2014). Finally, as a fourth independent evidence, we
included the differential regulation of each of the candidate AKT
sites under inhibition by AKT inhibitor VIII in insulin-stimulated
HeLa cells described above.
Expanded View for this article is available online.
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